Eagle Asset Management Inc Haemonetics Corp Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Eagle Asset Management Inc holds 100,565 shares of HAE stock, worth $6.94 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

100,565

Previous 219,201 54.12%

Holding current value

$6.94 Million

Previous $18.1 Million 55.43%

% of portfolio

0.05%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.45 - $91.58 $8.6 Million - $10.9 Million	-118,636 Reduced 54.12%	100,565 $8.08 Million
Q2 2024 Aug 12, 2024	SELL	$81.24 - $97.37 $3.45 Million - $4.14 Million	-42,472 Reduced 16.23%	219,201 $18.1 Million
Q1 2024 May 09, 2024	SELL	$71.24 - $85.35 $773,167 - $926,303	-10,853 Reduced 3.98%	261,673 $22.3 Million
Q4 2023 Feb 12, 2024	BUY	$80.59 - $92.61 $312,930 - $359,604	3,883 Added 1.45%	272,526 $23.3 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $563,719 - $638,349	6,828 Added 2.61%	268,643 $24.1 Million
Q2 2023 Aug 09, 2023	BUY	$80.84 - $89.45 $3.5 Million - $3.87 Million	43,270 Added 19.8%	261,815 $22.3 Million
Q1 2023 May 08, 2023	BUY	$72.75 - $90.6 $15.9 Million - $19.8 Million	218,545 New	218,545 $18.1 Million
Q2 2021 Aug 11, 2021	SELL	$51.81 - $118.56 $2.96 Million - $6.78 Million	-57,172 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $469,683 - $590,139	-4,231 Reduced 6.89%	57,172 $6.41 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $626,663 - $846,966	-7,061 Reduced 10.31%	61,403 $7.29 Million
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $36,009 - $44,544	-476 Reduced 0.69%	68,464 $5.95 Million
Q2 2020 Aug 12, 2020	SELL	$84.96 - $118.91 $38.5 Million - $53.9 Million	-452,922 Reduced 86.79%	68,940 $6.07 Million
Q1 2020 May 11, 2020	BUY	$74.34 - $121.82 $630,477 - $1.03 Million	8,481 Added 1.65%	521,862 $52 Million
Q4 2019 Feb 07, 2020	SELL	$114.37 - $129.46 $9.44 Million - $10.7 Million	-82,551 Reduced 13.85%	513,381 $59 Million
Q3 2019 Nov 04, 2019	BUY	$117.16 - $138.52 $1.99 Million - $2.35 Million	16,962 Added 2.93%	595,932 $75.2 Million
Q2 2019 Aug 05, 2019	BUY	$81.74 - $120.34 $1.37 Million - $2.02 Million	16,803 Added 2.99%	578,970 $69.7 Million
Q1 2019 May 01, 2019	SELL	$83.25 - $102.12 $4,828 - $5,922	-58 Reduced 0.01%	562,167 $49.2 Million
Q4 2018 Feb 11, 2019	BUY	$90.66 - $116.63 $9.31 Million - $12 Million	102,649 Added 22.34%	562,225 $56.3 Million
Q3 2018 Nov 08, 2018	BUY	$89.96 - $114.58 $41.3 Million - $52.7 Million	459,576 New	459,576 $52.7 Million

Others Institutions Holding HAE

# of Institutions

334

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Haemonetics Corp Transaction History